Back to Top Skip to main content

WRAIR begins Phase 1 clinical trial of Marburg vaccine

The WRAIR study evaluates the VRC-MARADC087-00-VP vaccine, developed by the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. (U.S. Army file photo) The WRAIR study evaluates the VRC-MARADC087-00-VP vaccine, developed by the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. (U.S. Army file photo)

Recommended Content:

Immunization Healthcare | Immunizations

SILVER SPRING, Md. — The Walter Reed Army Institute of Research (WRAIR) recently administered the first vaccine in a Phase 1 clinical trial to evaluate the safety and immunogenicity of a Marburg vaccine candidate in healthy adult volunteers.

The WRAIR study evaluates the VRC-MARADC087-00-VP vaccine, developed by the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). The recombinant chimpanzee adenovirus type 3-vectored Marburg virus vaccine candidate being tested is aimed at stimulating rapid but durable immunity. This vaccination strategy is considered optimal to protect both first-line health workers and general populations in areas where outbreaks occur.

“Given the recent deadly outbreak of Marburg virus in Uganda, there is a critical need to develop a safe and effective vaccine which has the potential to protect our soldiers and the public from this serious threat,” said Army Lt. Col. Melinda Hamer, Chief of the WRAIR Clinical Trials Center in Silver Spring, Maryland, where the trial is being conducted.

Forty healthy, adult volunteers will be enrolled and assigned into one of two groups to evaluate different vaccine dosages. Volunteers will be closely followed over the course of approximately one year after vaccination for safety and immune system response.

The Marburg virus is in the same family as Ebola and causes severe hemorrhagic fever in humans. Case fatality rates in Marburg outbreaks have ranged from 24% to 88%. The most recent outbreak occurred in Uganda in 2017.

WRAIR conducted the first Ebola vaccine clinical trial in Africa in 2009, testing an early vaccine candidate also developed by the VRC at NIAID. During the 2014 West Africa Ebola outbreak, WRAIR conceived of, and then initiated a Phase I clinical trial of the VSV-EBOV vaccine candidate over a period of just 11 weeks at its CTC. WRAIR has conducted six Ebola vaccine studies to date.

“This first-in-human trial of the NIH vaccine is part of an important inter-agency effort by the US government to anticipate and counter emerging infectious threats to the Americans, both military and civilian, at home and abroad,” added Dr. Kayvon Modjarrad, the Director of the Emerging Infectious Diseases Branch at WRAIR.

You also may be interested in...

MHS emphasizes importance of vaccinations

Article
7/22/2020
Healthcare worker giving vaccine to soldier; both wearing masks

Get questions answered during live Q&A on July 23

Recommended Content:

TRICARE Health Program | Coronavirus | Immunization Healthcare | July Toolkit

Defending the Homeland: WRNMMC Operates Drive-Up Immunization Clinic

Article
6/3/2020
Nurse giving a shot to a girl; both wearing masks

Parents and others (are encouraged) to maintain their immunization health during COVID-19.

Recommended Content:

Coronavirus | Immunization Healthcare

Recommendations for Mass Immunization Events During Pandemic Conditions

Fact Sheet
5/27/2020

During pandemic conditions, planners of mass immunization events need to consider additional measures to minimize risk of COVID-19 or similar infectious disease transmission.

Recommended Content:

Immunization Healthcare

CDC maintains childhood immunization guidelines during COVID-19

Article
5/1/2020
A child receives a vaccine during a visit to the clinic.

What you need to know about getting your child vaccinated

Recommended Content:

Coronavirus | Immunization Healthcare | Vaccine-Preventable Diseases

Immunization Tool Kit 9th Edition

Publication
4/30/2020

A practical reference that facilitates and enhances the global delivery of quality immunization healthcare to Department of Defense (DoD) beneficiaries and employees. The Defense Health Agency Immunization Healthcare Division (DHA-IHD) publishes the Immunization Tool Kit based on national recommendations, evidenced-based, peer-reviewed published medical literature, and clinical practice guidelines.

Recommended Content:

Immunization Healthcare

Amid COVID-19, seasonal influenza still a threat to force readiness

Article
4/29/2020
Hospital Corpsman administers a flu shot to a navy officer.

New Southern Hemisphere flu vaccine available May 2020

Recommended Content:

Coronavirus | Influenza Summary and Reports | Immunization Healthcare | Vaccine-Preventable Diseases | Influenza, Southern Hemisphere

DHA IPM 20-002: Southern Hemisphere Influenza Vaccination Program

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), establishes the Defense Health Agency’s (DHA) procedures to implement instructions, assign responsibilities, and prescribe procedures for the Southern Hemisphere Influenza Vaccination Program. All Active Duty, Selected Reserve, and National Guard members receive an annual influenza vaccination. Personnel who are traveling to, conducting a permanent change of station to, or are located in the Southern Hemisphere will receive the Southern Hemisphere influenza vaccine or obtain an exemption (e.g., medical or administrative) in accordance with guidance in paragraph 6.a. of Attachment 2. Military personnel residing in the Southern Hemisphere who have received the Southern Hemisphere influenza vaccine in accordance with Appendix 1, meet the annual influenza immunization requirement.

General Best Practice Guidelines for Immunization

Publication
2/21/2020

The Centers for Disease Control and Prevention (CDC) recommends routine vaccination to prevent 17 vaccine-preventable diseases that occur in infants, children, adolescents, or adults. This report provides information for clinicians and other health care providers about concerns that commonly arise when vaccinating persons of various ages.

Recommended Content:

Immunization Healthcare | Vaccine Recommendations | Continuous Quality Immunization Improvement Process (CQIIP) and Virtual Continuous Quality Immunization Improvement Process (VCQIIP)

Sorry flu, not this year

Article
1/27/2020
U.S. Air Force Kathryn Klein, right, an aerospace medical service specialist with 182nd Medical Group, Illinois Air National Guard, administers an influenza vaccination during drill weekend at the 182nd Airlift Wing in Peoria, Ill., Dec. 8, 2019. According to the Centers for Disease Control and Prevention, the flu is a contagious respiratory illness caused by influenza viruses, and the best prevention is getting a flu vaccine each year. (U.S. Air National Guard photo by Senior Airman Paul R. Helmig II)

The Defense Logistics Agency Troop Support Medical supply chain teamed with Department of Defense partners to provide 3.4 million doses of the influenza vaccine to service members, dependents and retirees.

Recommended Content:

Immunization Healthcare | Health Readiness | Influenza Summary and Reports | Influenza, Northern Hemisphere | Seasonal Influenza Resource Center 2020-21

Mid-season flu activity increase: How to keep healthy

Article
1/22/2020
Navy Hospital Corpsman Kenny Liu, from San Jose, assigned to USS Gerald R. Ford's medical department, prepares a needle with a flu vaccination in the ship's hangar bay. (U.S. Navy photo by Mass Communication Specialist Seaman Apprentice Angel Thuy Jaskuloski)

Despite reports of increased flu activity in the U.S., the Military Health System remains vigilant

Recommended Content:

Immunization Healthcare | Influenza Summary and Reports | Health Readiness | Influenza, Northern Hemisphere | Influenza, Southern Hemisphere | Vaccine Recommendations | Vaccine-Preventable Diseases | Armed Forces Health Surveillance Branch

DTRA contributes to historic Ebola vaccine effort

Article
1/17/2020
Air Force Staff Sgt. Lee Nembhard, an aeromedical evacuation technician assigned to the 375th Aeromedical Evacuation Squadron from Scott Air Force Base, Illinois, straps a simulated Ebola patient to a litter during a Transport Isolation System training exercise at Joint Base Charleston, South Carolina. (U.S. Air Force photo by Senior Airman Megan Munoz)

U.S. Food and Drug Administration approves new Ebola vaccine

Recommended Content:

Immunization Healthcare | Immunizations | Global Emerging Infections Surveillance | Global Health Engagement | Global Health Engagement

HPV vaccine age limit raised by FDA to age 45

Article
1/14/2020
https://www.nfid.org/infectious-diseases/hpv/ Recent CDC and FDA guidance recommends that men and women up to 45 years of age get vaccinated to protect against the Human papillomavirus (HPV). HPV is the most common sexually transmitted infection and can cause certain cancers and genital warts. More than 14 million new HPV infections occur in the U.S. each year, and about 80 percent of sexually active men and women are infected with HPV at some point in their lives. (National Foundation for Infectious Diseases image)

HPV shot protects against a host of diseases in men, women

Recommended Content:

Conditions and Treatments | Health Readiness | Preventive Health | Men's Health | Women's Health | Immunization Healthcare | Vaccine-Preventable Diseases | Vaccine Recommendations

World AIDS Day puts spotlight on landmark DoD study

Article
12/2/2019
Dr. John Mascola, director of the National Institutes of Health Vaccine Research Center, discusses HIV vaccine progress at the Walter Reed Army Institute of Research, Nov. 26, during a World AIDS Day commemoration.  (U.S. Army photo)

Vaccine study shows infection risk lowered by 31 percent, offering hope for future

Recommended Content:

Immunization Healthcare | Research and Innovation | Global Health Engagement

CDC Yellow Book

Publication
11/21/2019

CDC Health Information for International Travel 2020

Recommended Content:

Immunization Healthcare

Preventing seasonal influenza

Article
11/13/2019
Air Force Staff Sgt. Jaqueline Mbugua and members of the Massachusetts Air National Guard’s 102nd Medical Group traveled to the Roxy Theater on Joint Base Cape Cod to provide flu shots to Airmen Nov. 2, 2019. (U.S. Air Force photo by Tech. Sgt. Thomas Swanson).

The best way to prevent the flu is to get vaccinated every year

Recommended Content:

Health Readiness | Immunization Healthcare | Immunizations
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 6

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.